Outpatient treatment of low‐risk neutropenic fever in cancer patients using oral moxifloxacin
G Chamilos, A Bamias, E Efstathiou, PM Zorzou… - Cancer, 2005 - Wiley Online Library
BACKGROUND Oral‐based antibiotic therapy is the standard of care in the management of
cancer patients with low‐risk neutropenic fever. Nevertheless, to the authors' knowledge, the …
cancer patients with low‐risk neutropenic fever. Nevertheless, to the authors' knowledge, the …
Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge
C Sebban, S Dussart, C Fuhrmann… - Supportive Care in …, 2008 - Springer
Goals of work Patients with low-risk neutropenic fever as defined by the Multinational
Association of Supportive Care in Cancer (MASCC) score might benefit from ambulatory …
Association of Supportive Care in Cancer (MASCC) score might benefit from ambulatory …
In vitro antimicrobial activity of moxifloxacin compared to other quinolones against recent clinical bacterial isolates from hospitalized and community-based cancer …
KVI Rolston, S Frisbee-Hume, B LeBlanc… - … and infectious disease, 2003 - Elsevier
The in vitro spectrum of moxifloxacin (a C-8-methoxyquinolone) was compared to that of
ciprofloxacin and levofloxacin against 924 recent clinical isolates from cancer patients …
ciprofloxacin and levofloxacin against 924 recent clinical isolates from cancer patients …
Chronic bacterial prostatitis and relapsing Enterococcus faecalis bacteraemia successfully treated with moxifloxacin.
C Nieuwkoop, LG Visser, JHM Groeneveld, EJ Kuijper - 2008 - cabidigitallibrary.org
A 47-year-old man was admitted to undergo a cadaveric kidney transplantation. Two weeks
after his surgery, he developed signs of septicaemia from a urinary tract infection which were …
after his surgery, he developed signs of septicaemia from a urinary tract infection which were …
Quinolone antibiotics: the development of moxifloxacin
U Petersen - Analogue‐based Drug Discovery, 2006 - Wiley Online Library
A patent application from ICI [13] in 1954 already described the antibacterial activity of
quinolonecarboxylic acids such as 1, which were however disregarded. It was not until …
quinolonecarboxylic acids such as 1, which were however disregarded. It was not until …
[PDF][PDF] Nemonoxacin has potent activity against gram-positive, but not gram-negative clinical isolates
ZX Li, YN Liu, R Wang, AM Li - Clin Ter, 2015 - clinicaterapeutica.it
Objective. The aim of the current study was to analyze the susceptibility of gram-positive and-
negative clinical isolates to a novel des-F (6)-quinolone (nemonoxacin) and other selected …
negative clinical isolates to a novel des-F (6)-quinolone (nemonoxacin) and other selected …
[PDF][PDF] Compared Antibiotic Resistance Patterns of Methicillin-Resistant Staphylococcus aureus and Methicillin-Sensitive Staphylococcus aureus
AB Taha, SMS Al-Salihi - Impact of a health educational program on … - researchgate.net
Background and O bjectives: antibiotic resistance of Staphylococcus aureus especially
methicillin-resistant Staphylococcus aureus have been problem for clinicians worldwide …
methicillin-resistant Staphylococcus aureus have been problem for clinicians worldwide …